Semaglutide once a week in adults with overweight or obesity, with or without type 2 diabetes in an east Asian population (STEP 6): a randomised, double-blind, double-dummy, placebo-controlled, phase 3a trial
Toranomon Hospital · Novo Nordisk (Denmark) · +6 more institutions
Indexed incrossrefpubmed
Abstract
No abstract available for this paper.
Citation impact
296
total citations
- FWCI
- 35.76
- Percentile
- 100%
- References
- 28
Citations per year
Authors
9Topics & keywords
Topics
Keywords
- Medicine
- Semaglutide
- Overweight
- Type 2 diabetes
- Double blind
- Placebo
- Obesity
- Population
UN Sustainable Development Goals
- Good health and well-being
No related works found for this paper.